A215380 Stock Overview
WOOJUNG BIO, Inc. provides research and laboratory services in Korea.
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 0/6 |
| Financial Health | 1/6 |
| Dividends | 0/6 |
WOOJUNG BIO, Inc. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | ₩1,637.00 |
| 52 Week High | ₩4,125.00 |
| 52 Week Low | ₩1,620.00 |
| Beta | 0.71 |
| 1 Month Change | -13.16% |
| 3 Month Change | -13.66% |
| 1 Year Change | -41.12% |
| 3 Year Change | -77.26% |
| 5 Year Change | -75.61% |
| Change since IPO | -71.47% |
Recent News & Updates
Recent updates
Shareholder Returns
| A215380 | KR Life Sciences | KR Market | |
|---|---|---|---|
| 7D | -1.1% | -0.5% | -0.4% |
| 1Y | -41.1% | 2.2% | 4.5% |
Return vs Industry: A215380 underperformed the KR Life Sciences industry which returned 2.2% over the past year.
Return vs Market: A215380 underperformed the KR Market which returned 4.5% over the past year.
Price Volatility
| A215380 volatility | |
|---|---|
| A215380 Average Weekly Movement | 6.4% |
| Life Sciences Industry Average Movement | 7.4% |
| Market Average Movement | 5.2% |
| 10% most volatile stocks in KR Market | 11.8% |
| 10% least volatile stocks in KR Market | 2.4% |
Stable Share Price: A215380's share price has been volatile over the past 3 months.
Volatility Over Time: A215380's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1989 | n/a | n/a | www.woojungbsc.co.kr |
WOOJUNG BIO, Inc. provides research and laboratory services in Korea. The company offers environmental infection control. It also provides construction solutions, such as preventing clean and infected; hospital negative pressure isolation ward; pharmaceutical company's aseptic production rooms; general and animal laboratory; high-risk pathogen research facility; and HEPA box air conditioning systems.
WOOJUNG BIO, Inc. Fundamentals Summary
| A215380 fundamental statistics | |
|---|---|
| Market cap | ₩22.33b |
| Earnings (TTM) | -₩5.05b |
| Revenue (TTM) | ₩38.62b |
0.6x
P/S Ratio-4.4x
P/E RatioIs A215380 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| A215380 income statement (TTM) | |
|---|---|
| Revenue | ₩38.62b |
| Cost of Revenue | ₩32.43b |
| Gross Profit | ₩6.19b |
| Other Expenses | ₩11.24b |
| Earnings | -₩5.05b |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
| Earnings per share (EPS) | -370.53 |
| Gross Margin | 16.03% |
| Net Profit Margin | -13.09% |
| Debt/Equity Ratio | 230.5% |
How did A215380 perform over the long term?
See historical performance and comparison